NZIER Report


  • Community pharmaceuticals: Expenditure trends 

    Siddharth, Prince (New Zealand Institute of Economic Research, 2018-12-30)
    The report highlights that the amount of investment in medicines as a percentage of total DHB funding was estimated to be 8.1% in real terms in 2007, but since then has fallen. Investment as a percentage of DHB funding declined sharply in 2017/18 from ...
  • How does the dairy sector share its growth? An analysis of the flow-on benefits of dairy’s revenue generation 

    Destremau, Killian; Siddharth., Prince (New Zealand Institute of Economic Research, 2018-10-30)
    DCANZ asked NZIER to look beyond dairy’s high-level impact on the New Zealand economy and delve into how income from dairy is distributed across New Zealand regions, other businesses, and incomes.
  • PHARMAC economic analysis and “savings” claims 

    Research, New Zealand Institute of Economic (New Zealand Institute of Economic Research, 2018-10-15)
    PHARMAC frequently claims that it achieves savings through its negotiations practices and approvals process for new medicines. In the 2017 financial year, PHARMAC claims to have achieved $52 million in savings for New Zealand. PHARMAC further claims ...
  • International regulatory cooperation: Case studies and lessons learnt 

    Gill, Derek (New Zealand Institute of Economic Research, 2018-08-30)
    The New Zealand Ministry of Business, Innovation and Employment (MBIE) has developed a toolkit that shows how IRC can take many forms along a spectrum. At one end of the continuum is unilateral recognition through adoption of another country’s regulatory ...

View more